Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$35.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Stomach upheavalarcity of potassiumIf you are experiencing a medical problem, please consult with a healthcare professional before taking this product.
While this product is suitable for use by individuals who are allergic to Provera or other similar medications, it is not suitable for use by women or children. This product should not be taken by individuals under the age of 18 or by people who have a history of severe gastrointestinal problems. Individuals who are taking other medications may be at a higher risk for side effects of this product.
This product should not be taken by individuals who are experiencing severe allergic reactions to any medications or by people who have a history of severe gastrointestinal problems. Individuals with a history of severe allergic reactions to medications should talk to their healthcare provider before using this product.
Should I take medication for high blood pressure?Should I take medication for depression?This product should not be taken by individuals who are experiencing a medical problem, including depression. This product should not be taken by individuals with a history of severe allergic reactions to any medications, including those that are known to interact with Provera. People with a history of severe allergic reactions to medications should talk to their healthcare provider before using this product.
If you have any questions about this product, contact the manufacturer via the contact details.
Medicine for blood pressureHealthylife provides a complete list of approved medications for use in medical treatment for individuals with diabetes, hypertension, high blood pressure, and/or heart failure. If you are experiencing a medical problem, contact your doctor or pharmacist.
Diabetes management planHealthylife provides a comprehensive diabetes management plan that covers all medical conditions, including diabetes, high blood pressure, and/or heart failure. If you are experiencing a medical problem, contact your healthcare provider or visit your local pharmacy to find out how this medicine may be prescribed and take.
Healthylife also provides a comprehensive diabetes management plan that covers all medical conditions, including diabetes, high blood pressure, and/or heart failure.
Diuretic agentHealthylife provides a comprehensive diuretic agent for use in medical treatment for individuals with conditions that may contribute to fluid accumulation in the body.
Provera, manufactured by Bayer Healthcare Pvt. Ltd., is a contraceptive drug used to prevent pregnancy. It contains a synthetic hormone called oestrogen, which prevents ovulation, thickening cervical mucus, and thinning the uterine lining.
In the UK, Provera is prescribed to women who are over the age of 40 years old. It is available in pharmacies, usually in lower doses, to reduce the risk of side effects. It is also used to reduce the risk of blood clots, strokes, deep vein thrombosis (DVT), and pulmonary embolism (PE).
In other countries, Provera is available as a prescription-only medication. It is not usually recommended for use in women who are pregnant or may become pregnant, as it can cause birth defects in the developing fetus.
Take one tablet about 1 hour before the expected sexual activity.
Swallow the tablet whole with water.
Do not take more than 1 tablet in 24 hours.
The dose should be taken with food to avoid potential drowsiness.
Consult your doctor if you have any medical conditions, especially if they need you for treatment or if you are pregnant or breastfeeding.
Provera should not be used in the following cases:
Allergy to oestrogen or other progestogen hormones
Breast-feeding or ovulation
Pregnancy-related birth defects
Provera is not recommended for use by women who have a history of breast cancer or uterine cancer.
Common side effects may include:
Nausea and vomiting
Hot flashes
Visual disturbances including blurring, blurred vision
Nasal congestion
Hot and sweating
Upset stomach
Uterine bleeding
Upper respiratory infection symptoms
Pulmonary infection
Inform your doctor if you have a history of blood clots, breast cancer, uterine cancer, liver cancer, blood disorder, or a history of stroke or heart attack before taking this medicine. Provera should be avoided in women who are pregnant or may become pregnant. Provera is not recommended for use during breastfeeding. Inform your doctor of any history or symptoms of breast cancer before taking this medicine. Provera is not recommended for use by women who have a history of blood clots or breast cancer.
Use with caution in patients with a history of breast cancer or uterine cancer. Inform your doctor if you have a history of high or low blood pressure, high cholesterol, diabetes, or if you are pregnant or may become pregnant. If you are taking medication, your doctor will monitor your progress and make certain necessary checks in case of missed doses.
Inform your doctor if you are breastfeeding, or planning to breastfeed.
Provera should not be used by women who are pregnant or may become pregnant as it may harm their unborn baby. Use the medicine during the third trimester of pregnancy to prevent pregnancy.
Provera is a reliable and cost-effective option for managing heavy bleeding, tackling menstrual pain, and managing your menstrual cycle. Its easy to obtain, discreet formula, and reliable effectiveness mean it's your best buy. But be sure to follow the guidance provided in the product information leaflet to maximize your savings. Opt for tablets with a 10 mg/mL concentration and an effective injection. Women with heavy menstrual bleeding or premenstrual syndrome symptoms should use Provera for the shortest time. Remember, the active ingredient in Provera is not Progesterone but rather a progestin. This means it's easy to get, especially for women experiencing discomfort, difficulty premenstrual syndrome symptoms, or heavy bleeding. For best results, take the lowest strength tablet possible and try not to exceed the recommended dose. This will help to ensure that the bleeding continues and minimizes the discomfort. Provera.com.au recommends a 10 mg/mL concentration for the lowest possible dose. Women with heavy bleeding or premenstrual syndrome symptoms should use Provera for the shortest possible time. Taking more than the recommended dose can increase the risk of unwanted side effects.
Provera-free is a convenient way to manage heavy menstrual bleeding and reduce symptoms of PMS, such as premenstrual dysphoric disorder, or menstrual cramps. With discreet formula, easy-to-use injection, and reliable effectiveness, you'll be sure to enjoy your purchase with confidence.
Consider following the recommended dosage when using Provera for the first time. Be sure to continue taking the tablet for at least 12 hours after it is prescribed.
Show MoreBenefits ofProveraProvera-free
Provera-free:
A convenient and cost-effective way to manage heavy menstrual bleeding. Provera-free tablets provide a convenient and cost-effective way to manage a range of hormonal irregularities.
Provera-free tablets provide a convenient and cost-effective way to manage heavy menstrual bleeding.
Breast cancer is the third most common cancer in the United States, accounting for more than 3 million deaths per year. The global breast cancer burden is projected to rise in the next two decades and will reach $10.8 billion by 2030, depending on the number of cancers and their treatment strategies. Despite this high burden, many women are still experiencing breast cancer that has not responded to other therapeutic options. The current treatment of women with breast cancer, including the Provera® shot, has been shown to delay the disease progression and reduce the risk of recurrence and other adverse outcomes, including cancer death. However, the availability of these medicines for women with breast cancer does not provide the same quality of life as that provided by breast cancer treatment. To date, there is no evidence that the availability of Provera® has significantly impacted on the quality of life of women with breast cancer. Further research is required to explore the effects of these medicines on breast cancer. This study will determine whether the availability of Provera® improves mood, emotional regulation, sexual function, and quality of life in women with breast cancer. The study will also explore other treatment outcomes and address the potential impact of breast cancer on patients. Finally, this study will provide a foundation for future research aimed at determining the effect of Provera® on breast cancer risk.
Provera® is a combination of medroxyprogesterone acetate (Depo-Provera) and medroxyprogesterone acetate extended-release tablets, containing 10 mg of medroxyprogesterone acetate per tablet. Medroxyprogesterone acetate is the active ingredient in Depo-Provera, a form of birth control shot. Provera® is available in three strengths: 5 mg, 10 mg, and 15 mg. The combination contains: Depo-Provera, 10 mg/kg, and medroxyprogesterone acetate extended-release tablets.
This is a prospective, randomized, double-blind, phase 2, single-center, parallel-group, placebo-controlled, multicentre study in women with breast cancer who are being treated with Depo-Provera and medroxyprogesterone acetate, or who are not currently treated with Depo-Provera.
Women who are eligible for the study will be enrolled if: